These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24927576)

  • 1. Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage.
    Gregory MT; Park GY; Johnstone TC; Lee YS; Yang W; Lippard SJ
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9133-8. PubMed ID: 24927576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
    Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
    J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
    Park GY; Wilson JJ; Song Y; Lippard SJ
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
    Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
    Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
    J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
    Vaisman A; Masutani C; Hanaoka F; Chaney SG
    Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
    Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
    DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
    Riddell IA; Johnstone TC; Park GY; Lippard SJ
    Chemistry; 2016 May; 22(22):7574-81. PubMed ID: 27111128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chiral potential of phenanthriplatin and its influence on guanine binding.
    Johnstone TC; Lippard SJ
    J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
    Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
    PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monofunctional platinum(II) compounds and nucleolar stress: is phenanthriplatin unique?
    McDevitt CE; Yglesias MV; Mroz AM; Sutton EC; Yang MC; Hendon CH; DeRose VJ
    J Biol Inorg Chem; 2019 Sep; 24(6):899-908. PubMed ID: 31494760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of human DNA polymerase η-mediated chemoresistance to cisplatin.
    Zhao Y; Biertümpfel C; Gregory MT; Hua YJ; Hanaoka F; Yang W
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7269-74. PubMed ID: 22529383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
    Albertella MR; Green CM; Lehmann AR; O'Connor MJ
    Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationalization of the Superior Anticancer Activity of Phenanthriplatin: An In-Depth Computational Exploration.
    Dabbish E; Russo N; Sicilia E
    Chemistry; 2020 Jan; 26(1):259-268. PubMed ID: 31614021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA polymerase eta: A potential pharmacological target for cancer therapy.
    Saha P; Mandal T; Talukdar AD; Kumar D; Kumar S; Tripathi PP; Wang QE; Srivastava AK
    J Cell Physiol; 2021 Jun; 236(6):4106-4120. PubMed ID: 33184862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of platinum-DNA adduct repair.
    Chaney SG; Vaisman A
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
    Havener JM; Nick McElhinny SA; Bassett E; Gauger M; Ramsden DA; Chaney SG
    Biochemistry; 2003 Feb; 42(6):1777-88. PubMed ID: 12578393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
    Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
    J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
    Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
    Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing and Bypass of a Site-Specific DNA Adduct of the Cytotoxic Platinum-Acridinylthiourea Conjugate by Polymerases Involved in DNA Repair: Biochemical and Thermodynamic Aspects.
    Hreusova M; Brabec V; Novakova O
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.